Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
Costa
L J
LJ
Rodriguez
V
V
Porrata
L F
LF
Lacy
M Q
MQ
Elliott
M A
MA
Gertz
M A
MA
Gastineau
D A
DA
Litzow
M R
MR
D000293:Adolescent; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced; D008224:Lymphoma, Follicular / Q000188:drug therapy / Q000601:surgery; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000601:surgery; D009190:Myelodysplastic Syndromes / Q000139:chemically induced*; D009369:Neoplasms / Q000188:drug therapy* / Q000601:surgery*; D016609:Neoplasms, Second Primary / Q000517:prevention & control; D012512:Sarcoma, Ewing / Q000188:drug therapy / Q000601:surgery; D014182:Transplantation, Autologous
D000970:Antineoplastic Agents